Is the increased risk for MAFLD patients to develop severe COVID-19 linked to perturbation of the gut-liver axis?
- PMID: 32574578
- PMCID: PMC7305888
- DOI: 10.1016/j.jhep.2020.05.051
Is the increased risk for MAFLD patients to develop severe COVID-19 linked to perturbation of the gut-liver axis?
Keywords: COVID-19; Gut-liver axis; Inflammation; Intestinal permeability; MAFLD; Obesity.
Conflict of interest statement
Conflict of interest The authors declare no conflicts of interest that pertain to this work. Please refer to the accompanying ICMJE disclosure forms for further details.
Comment on
-
Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study.J Hepatol. 2020 Aug;73(2):451-453. doi: 10.1016/j.jhep.2020.03.044. Epub 2020 Apr 8. J Hepatol. 2020. PMID: 32278005 Free PMC article. No abstract available.
-
Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis.J Hepatol. 2020 Sep;73(3):719-721. doi: 10.1016/j.jhep.2020.04.027. Epub 2020 Apr 26. J Hepatol. 2020. PMID: 32348790 Free PMC article. No abstract available.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical